Actelion Ltd Price Target Increased to €79.00 by Analysts at Vontobel (ATLN)
Equities research analysts at Vontobel upped their price target on shares of Actelion Ltd (VTX:ATLN) from €72.00 ($97.30) to €79.00 ($106.76) in a research note issued to investors on Friday, Analyst Ratings Network.com reports. The firm currently has a “buy” rating on the stock.
Actelion Ltd (VTX:ATLN) traded up 4.01% during mid-day trading on Friday, hitting CHK 63.55. 417,513 shares of the company’s stock traded hands. Actelion Ltd has a one year low of CHK 42.85 and a one year high of CHK 66.25. The stock has a 50-day moving average of CHK 63.92 and a 200-day moving average of CHK 58.80.
Separately, analysts at UBS AG upgraded shares of Actelion Ltd to a “preferred list” rating in a research note to investors on Friday, September 27th. Four analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and a consensus target price of €65.85 ($88.99).
Actelion Ltd is a Switzerland-based biopharmaceutical holding company that focuses on the discovery, development and commercialization of small molecule drugs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.